Literature DB >> 3891168

Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.

A Rifai, K Millard.   

Abstract

Clearance kinetics and renal deposition of soluble IgA immune complexes (IgA IC) were examined to determine the nephritogenic potential of IgA molecular form in mediating experimental IgA nephropathy. The immune complexes were prepared by mixing purified radiolabelled monomeric (mIgA) or polymeric (pIgA) IgA anti-dinitrophenyl (DNP), derived from MOPC-315 myeloma, with DNP conjugated Ficoll (DNP8-Ficoll). Clearance of IgAIC from the circulation was curve fitted by two exponential components. The first component was similar for both mIgA IC and pIgA IC. The second component was slightly more rapid for mIgA IC than for pIgA IC. Immunofluorescence studies, however, showed that only pIgA IC deposited in the kidneys. Analysis of IgA IC by gradient polyacrylamide gel electrophoresis indicated that mIgA formed only small latticed complexes. The critical role of IgA IC lattice size in renal deposition was confirmed by demonstrating that large latticed mIgA IC, prepared by covalent cross-linking mIgA with a specific affinity labelling antigen, deposited in the kidneys in a pattern similar to pIgA IC. Our results suggest that the monovalency of mIgA is responsible for its inability to form a large latticed nephritogenic complexes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891168      PMCID: PMC1577018     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

2.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

3.  The incidence of precipitating activity in monoclonal proteins.

Authors:  B R Andersen; J R McAninch; R Patterson
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

4.  Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460.

Authors:  B M Jaffe; H N Eisen; E S Simms; M Potter
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

5.  Symmetry of binding sites of a mouse IgA myeloma protein (MOPC 315).

Authors:  R Eisenberg; P Plotz
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

6.  Stable, soluble, model immune complexes made with a versatile multivalent affinity-labeling antigen.

Authors:  P H Plotz; A Rifai
Journal:  Biochemistry       Date:  1982-01-19       Impact factor: 3.162

7.  IgA subclasses in various secretions and in serum.

Authors:  D L Delacroix; C Dive; J C Rambaud; J P Vaerman
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

8.  IgA-containing circulating immune complexes in patients with igA nephropathy.

Authors:  R P Hall; I Stachura; J Cason; T L Whiteside; T J Lawley
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

9.  Detection of polymeric IgA in glomeruli from patients with IgA nephropathy.

Authors:  Y Tomino; H Sakai; M Miura; M Endoh; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

10.  Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.

Authors:  A Rifai; M Mannik
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  11 in total

1.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

3.  The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.

Authors:  Angelique L Rops; Carl G Figdor; Alie van der Schaaf; Wim P Tamboer; Marinka A Bakker; Jo H Berden; Henry B P M Dijkman; Eric J Steenbergen; Johan van der Vlag; Annemiek B van Spriel
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 4.  Immunopathogenesis of experimental IgA nephropathy.

Authors:  A Rifai
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Experimental IgA nephropathy: factors influencing IgA-immune complex deposition in the glomerulus.

Authors:  A Chen; C H Wei; W H Lee; C Y Lin
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.

Authors:  A Chen; S S Wong; A Rifai
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

7.  Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes.

Authors:  A J Peeters; A W van den Wall Bake; A D van Dalsen; M L Westedt
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

8.  Severe nephropathy in three adolescents with cystic fibrosis.

Authors:  M L Melzi; D Costantini; M Giani; A C Appiani; A M Giunta
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

9.  Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus.

Authors:  M T Kasaian; H Ikematsu; J E Balow; P Casali
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

Review 10.  Are there animal models of IgA nephropathy?

Authors:  Renato C Monteiro; Yusuke Suzuki
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.